Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04704934 |
|---|---|
| Brief Title: | Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04) |
| First Submitted : | January 8, 2021 |
| First Submitted that Met QC Criteria : | January 8, 2021 |
| First Posted : | January 12, 2021 |
| Last Update Submitted that Met QC Criteria : | February 20, 2024 |
| Last Update Posted : | February 21, 2024 |